MedTech News
AI system delivers comprehensive cancer diagnosis
The Hong Kong University of Science and Technology (HKUST) today launched SmartPath, a comprehensive artificial intelligence (AI) system designed to transform the entire pathology workflow for cancer care.
Personalized brain stimulation offers new hope for people with hard-to-treat epilepsy
Doctors and researchers at the University of Pittsburgh and UPMC have developed a new treatment for epilepsy patients who don’t respond to medication and aren’t candidates for surgery. Their approach, published in Nature Communications, uses deep brain stimulation (DBS) that is tailored to each patient’s unique brain wiring.
Electronic eye implant and AR glasses restore reading vision in people with sight loss
After being treated with an electronic eye implant paired with augmented-reality glasses, people with sight loss have recovered reading vision, reports a trial involving a UCL (University College London) and Moorfields Eye Hospital clinical researcher.
Retinal implant restores central vision in patients with advanced AMD, study shows
A wireless retinal implant can restore central vision in patients with advanced age-related macular degeneration (AMD), according to clinical trial results published in the New England Journal of Medicine.
Rectal “breathing” possible emergency treatment
The technique sounds so outlandish that it won an IgNobel prize in 2024. But the science behind rescuing people with blocked airways and clogged lungs by rectally delivering oxygen to the body is no joke.
ManaMed® Secures FDA 510(k) Clearance for PlasmaFlow® X — a Breakthrough, Compact Sequential Compression System with All-Day Battery
DENTON, Texas, Oct. 20, 2025 /PRNewswire/ — ManaMed today announced FDA 510(k) clearance for PlasmaFlow® X, the next-generation, tubeless sequential compression system that’s redefining recovery. Cleared as a Class II device, PlasmaFlow X is more compact, smarter, and longer-lasting—delivering powerful therapy in a sleek, portable package.
Glaukos picks up FDA approval for Epoxia incision-free keratoconus treatment
Glaukos (NYSE:GKOS) announced today that the FDA approved its Epoxia incision-free alternative to traditional corneal cross-linking procedures.
Rhythio wins FDA breakthrough nod for injectable electrode tech for defibrillation
Rhythio Medical announced today that it received FDA breakthrough device designation for its Injectable Electrode System.